- $121.74bn
- $128.83bn
- $23.20bn
- 100
- 21
- 84
- 76
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 21,390 | 17,858 | 19,628 | 20,752 | 23,196 |
Cost of Revenue | |||||
Gross Profit | 7,052 | 5,450 | 6,335 | 6,887 | 8,434 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 18,563 | 15,963 | 16,588 | 17,697 | 19,218 |
Operating Profit | 2,827 | 1,895 | 3,040 | 3,055 | 3,978 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 2,591 | 1,746 | 2,896 | 2,911 | 3,827 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2,213 | 1,415 | 2,146 | 2,466 | 3,223 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 2,211 | 1,410 | 2,144 | 2,462 | 3,218 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2,211 | 1,410 | 2,144 | 2,462 | 3,218 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.66 | 4.02 | 3.96 | 6.78 | 8.36 |
Dividends per Share |